IGFBP2 and pulmonary arterial hypertension: IGFBP-2 has been correlated with disease severity and right ventricular dysfunction in pediatric PAH, supporting its use as a prognostic biomarker for risk stratification in children (Griffiths et al., 2020; Ploegstra and Berger, 2021).